跳至主要内容
临床试验/JPRN-UMIN000028668
JPRN-UMIN000028668已完成未知

Canagliflozin heart failure with preserved ejection fraction study in type 2 diabetes mellitus - CANONICAL Study

ara Medical Univercity0 个研究点目标入组 80 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria 1) Type 1 DM 2) Treated with GLP-1 3) Patients who need insulin (severe ketosis, diabetic coma or pre-coma, severe infection, peri-operative, severe trauma) 4) Severe renal dysfunction or chronic renal failure during dialysis (In case of moderate renal dysfunction, patients are carefully judged the need for administration of canagliflozin) 5) ACS, CVD, myocarditis, contractile pericarditis, severe HVD (<12 weeks from IC) 6) NYHA IV 7) BMI<18.5kg/ m2 8) The pregnant, breastfeeder 9) Diagnosed or suspected malignant tumors (Patients who did not treat anti-cancer treatment within 1 year before consent can be entered.) 10) Inappropriate patients inappropriate to be included for some reasons

研究者

发起方
ara Medical Univercity

相似试验